|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn893577222 |
003 |
OCoLC |
005 |
20231120111819.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
141022s1981 flua o 100 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d E7B
|d OCLCO
|d EBLCP
|d OCLCO
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d YDXCP
|d UAB
|d OCLCQ
|d OCLCO
|d OCLCA
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|
019 |
|
|
|a 897642623
|a 899000562
|
020 |
|
|
|a 9781483165134
|q (electronic bk.)
|
020 |
|
|
|a 1483165132
|q (electronic bk.)
|
020 |
|
|
|z 9780444005663
|
035 |
|
|
|a (OCoLC)893577222
|z (OCoLC)897642623
|z (OCoLC)899000562
|
050 |
|
4 |
|a RC692
|
060 |
|
4 |
|a WG 550
|b P966 1980
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.136
|2 23
|
245 |
0 |
0 |
|a Prostaglandins, platelets, lipids :
|b new developments in atherosclerosis /
|c editors, Hadley L. Conn, Jr., Eugene DeFelice, Peter T. Kuo.
|
264 |
|
1 |
|a Miami, Fla :
|b Symposia Specialists,
|c 1981.
|
264 |
|
2 |
|a New York :
|b Distributed by Elsevier/North-Holland
|
264 |
|
4 |
|c �1981
|
300 |
|
|
|a 1 online resource (xii, 152 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a From a colloquium held in New York, April, 1980, sponsored by the Dept. of Medicine, Division of Cardiology, College of Medicine and Dentistry of New Jersey - Rutgers Medical School and co-sponsored by the Somerset County Chapter of the American Heart Association.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Prostaglandins, Platelets, Lipids: New Developments in Atherosclerosis; Copyright Page; Table of Contents; Acknowledgments; Introduction; Chapter 1. The Biological Importance and Therapeutic Potential of Prostacyclin; Objectives; Vascular Effects of Prostacyclin; Antithrombotic and Hemostatic Effects of Prostacyclin; Prostacyclin-Thromboxane A2 Balance and Antithrombotic Therapy; Prostacyclin, Fatty Acids and Thrombosis; Thromboxane A2-Prostacyclin Balance in Other Pathologicsd States; Therapeutic Uses of Prostacyclin; References; Self-Evaluation Quiz.
|
505 |
8 |
|
|a Chapter 2. Rationale for the Suppression of Platelet Aggregation and Thrombosis by Dietary Manipulation of Fatty AcidsObjectives; 3 Series PG Products: Synthetic Pathway and Platelet Effects; The Potential of PGD3 as an Antithrombotic Agent; Eicosapentaenoic Acid as a Potential Antithrombotic Substance; 1 Series PG Products and Platelet Aggregation -Mechanism of Action; Conclusion; References; Self-Evaluzation Quiz; Chapter 3. Prostaglandins and Hypertension; Objectives; Vascular Prostaglandins and Antihypertensive Mechanisms; Renal Prostaglandins and Antihypertensive Mechanisms; Summary.
|
505 |
8 |
|
|a AcknowledgmentsReferences; Self-Evaluation Quiz; Chapter 4. Antiplatelet Agents in the Prevention of Acute Coronary Events; Objectives; References; Self-Evaluation Quiz; Chapter 5. Role of Platelets in Stroke and Transient Ischemic Attack; Objectives; Thrombosis and Clinical Complications of Atherosclerosis; Thrombosis and the Clinical Complications of Atherosclerosis; Mechanisms in Thrombosis; Summary; References; Self-Evaluation Quiz; Chapter 6. Cardiovascular Actions of Prostacyclin in Man; Objectives; Hemodynamic Changes Induced by Prostacyclin (PGI2).
|
505 |
8 |
|
|a Prostacyclin Therapy for Peripheral Arterial DiseaseProstacyclin and Angina Pectoris; Side Effects of PGI2 Therapy; Conclusion; References; Self-Evaluation Quiz; Chapter 7. A Specific Inhibitor of Thrombin: Effects on the Arachidonic Acid Cascade; Objective; References; Self-Evaluation Quiz; Discussion; Answers to Self-Evaluation Quizzes; Subject Index.
|
520 |
|
|
|a Prostaglandins, Platelets, Lipids.
|
650 |
|
0 |
|a Arteriosclerosis
|v Congresses.
|
650 |
|
0 |
|a Blood platelets
|v Congresses.
|
650 |
|
0 |
|a Lipids
|v Congresses.
|
650 |
|
0 |
|a Prostaglandins
|v Congresses.
|
650 |
|
0 |
|a Arteriosclerosis.
|
650 |
|
0 |
|a Lipids
|x Metabolism.
|
650 |
|
0 |
|a Atherosclerotic plaque
|x Congresses.
|
650 |
|
0 |
|a Lipids
|x Congresses.
|
650 |
|
0 |
|a Blood platelets
|x Aggregation
|x Congresses.
|
650 |
|
2 |
|a Arteriosclerosis
|0 (DNLM)D001161
|
650 |
|
2 |
|a Arteriosclerosis
|x prevention & control
|0 (DNLM)D001161Q000517
|
650 |
|
2 |
|a Arteriosclerosis
|x therapy
|0 (DNLM)D001161Q000628
|
650 |
|
2 |
|a Blood Platelets
|x metabolism
|0 (DNLM)D001792Q000378
|
650 |
|
2 |
|a Lipid Metabolism
|0 (DNLM)D050356
|
650 |
|
2 |
|a Prostaglandins
|x metabolism
|0 (DNLM)D011453Q000378
|
650 |
|
6 |
|a Plaque d'ath�erome
|0 (CaQQLa)201-0232371
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Prostaglandines
|0 (CaQQLa)201-0031328
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Lipides
|0 (CaQQLa)201-0025366
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Sang
|0 (CaQQLa)201-0083585
|x Plaquettes
|0 (CaQQLa)201-0083585
|x Agr�egation
|0 (CaQQLa)201-0083585
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Art�erioscl�erose
|0 (CaQQLa)201-0001839
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Sang
|0 (CaQQLa)201-0016716
|x Plaquettes
|0 (CaQQLa)201-0016716
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Lipides
|0 (CaQQLa)201-0025366
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Art�erioscl�erose.
|0 (CaQQLa)201-0001839
|
650 |
|
6 |
|a Lipides
|x M�etabolisme.
|0 (CaQQLa)201-0025368
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Lipids
|x Metabolism
|2 fast
|0 (OCoLC)fst00999374
|
650 |
|
7 |
|a Blood platelets
|x Aggregation
|2 fast
|0 (OCoLC)fst00834784
|
650 |
|
7 |
|a Atherosclerotic plaque
|2 fast
|0 (OCoLC)fst00820023
|
650 |
|
7 |
|a Arteriosclerosis
|2 fast
|0 (OCoLC)fst00817075
|
650 |
|
7 |
|a Blood platelets
|2 fast
|0 (OCoLC)fst00834782
|
650 |
|
7 |
|a Lipids
|2 fast
|0 (OCoLC)fst00999367
|
650 |
|
7 |
|a Prostaglandins
|2 fast
|0 (OCoLC)fst01079463
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Conn, Hadley L.,
|e editor.
|
700 |
1 |
|
|a DeFelice, Eugene A.,
|e editor.
|
700 |
1 |
|
|a Kuo, Peter T.,
|e editor.
|
710 |
2 |
|
|a American Heart Association.
|b Somerset County Chapter.
|
710 |
2 |
|
|a Rutgers Medical School.
|b Department of Medicine.
|b Division of Cardiology.
|
776 |
0 |
8 |
|i Print version:
|t Prostaglandins, platelets, lipids
|z 9780444005663
|w (DLC) 80053262
|w (OCoLC)8573370
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444005663
|z Texto completo
|